Another Award for Synaffix: ‘Business Development Team of Year’ at the Scrip Awards
AMSTERDAM, THE NETHERLANDS, December 13, 2022 – Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that the Company has been awarded ‘Business Development Team of Year’ at the annual Scrip Awards ceremony held on the 30th of November, at the Royal Lancaster in London, UK. This award follows shortly after securing ‘Biotech Company of the Year 2022’ at the annual LSX, European Lifestars Awards Ceremony last month in London and ‘Best ADC Platform Technology’ at the World ADC Conference 2022 in September.
